Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Halucenex Life Sciences Inc.

32 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 20 Safety 11 Receptor Pharmacology 11 Review Article 10 Anxiety 10 Clinical Trial 9 Pharmacology 6 Mechanism of Action 6 Animal Study 5 Systematic Review 5 Toxicity 4 Neuroplasticity 4

Journals

ClinicalTrials.gov 5 bioRxiv 3 Case Medical Research 3 Biological Psychiatry 2 Biomolecules 1 University of Groningen research database (University of Groningen / Centre for Information Technology) 1 Psychedelic Medicine 1 American Journal of Ophthalmology Case Reports 1

Publication history

Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28 Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderClinicalTrials.gov · 2026-04-21 Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-21 Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-03 Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptomsbioRxiv · 2026-01-14 Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping ReviewPsychedelic Medicine · 2025-11-23 Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushroomsAmerican Journal of Ophthalmology Case Reports · 2025-06-01 Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07 13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08 Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.Addiction (Abingdon, England) · 2025-01-15 Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Health Disorders: A Scoping Review ProtocolPsyArXiv · 2024-10-06 Identifying Three Psilocybin Use Patterns by Frequency and QuantityJournal of Studies on Alcohol and Drugs · 2024-08-22 Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case reportFrontiers in Psychiatry · 2024-07-15 Assessing the Feasibility of a Custom Psychedelic-assisted Group Program on Mental and Physical Health in First RespondersClinicalTrials.gov · 2024-06-23 Hypertensive Emergency Secondary to Combining Psilocybin Mushrooms, Extended Release Dextroamphetamine-Amphetamine, and TranylcypromineJournal of Psychoactive Drugs · 2024-06-20 Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.Unknown journal · 2024-03-31 A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.Unknown journal · 2024-01-17 Evaluating the Effect of Length of Time on Selective Serotonin Reuptake Inhibitors (SSRIs) on the Response to Psilocybin-assisted Therapy in Individuals With Mild-moderate Major Depressive Disorder (MDD)ClinicalTrials.gov · 2023-07-05 Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress DisorderClinicalTrials.gov · 2023-06-28 118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09 Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-04 Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.Unknown journal · 2022-11-21 [Treatment-resistant depression. From classification to new therapies.]Rivista di psichiatria · 2022-10-31 Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in AdultsClinicalTrials.gov · 2022-06-29 Neuropharmacological analysis of the anti-addictive and therapeutic effects of psilocybinSURG Journal · 2022-05-31 Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.Scientific Reports · 2021-11-17 Psilocybin in the treatment of anorexia nervosa: The English transition of a French 1959 case studyAnnales Médico-psychologiques revue psychiatrique · 2021-09-27 Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants.Unknown journal · 2021-01-10 Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's DiseaseCase Medical Research · 2019-10-09 Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsCase Medical Research · 2019-04-11 A Study of Psilocybin for Major Depressive Disorder (MDD)Case Medical Research · 2019-03-06

Author directory